نتایج جستجو برای: onset type eoad

تعداد نتایج: 1494578  

Journal: :Genetic testing and molecular biomarkers 2012
Belinda Rahman Bettina Meiser Perminder Sachdev Kristine Barlow-Stewart Margaret Otlowski Elvira Zilliacus Peter Schofield

Alzheimer disease (AD) is a genetically heterogenous disorder; in rare cases autosomal dominantly inherited mutations typically cause early-onset familial AD (EOAD), whereas the risk for late-onset AD (LOAD) is generally modulated by genetic variants with relatively low penetrance but high prevalence, with variants in apolipoprotein E (APOE) being a firmly established risk factor. This article ...

Journal: :Journal of applied genetics 2003
Anna Kowalska Mieczyslaw Wender Jolanta Florczak Danuta Pruchnik-Wolinska Renata Modestowicz Józef Szczech Grzegorz Rossa Wojciech Kozubski

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss and personality changes. Pathological hallmarks of AD are: deposition of amyloid plaques and neurofibrillary tangles in the brain, accompanied by neuronal and synaptic loss. The genetic background of AD is heterogeneous and strongly depends on the form of the disease. In most of the families with e...

Journal: :Neurobiology of Aging 2018
Jan Verheijen Julie van der Zee Ilse Gijselinck Tobi Van den Bossche Lubina Dillen Bavo Heeman Estrella Gómez-Tortosa Albert Lladó Raquel Sanchez-Valle Caroline Graff Pau Pastor Maria A. Pastor Luisa Benussi Roberta Ghidoni Giuliano Binetti Jordi Clarimon Alexandre de Mendonça Ellen Gelpi Magda Tsolaki Janine Diehl-Schmid Benedetta Nacmias Maria Rosário Almeida Barbara Borroni Radoslav Matej Agustín Ruiz Sebastiaan Engelborghs Rik Vandenberghe Peter P. De Deyn Marc Cruts Christine Van Broeckhoven Kristel Sleegers

TANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in the disease course. We performed targeted resequencing of TBK1 in 1253 early onset Alzheimer's disease (EOAD) patients from 8 European countries to investigate whether pathogenic TBK1 mutations are en...

Journal: :International psychogeriatrics 2014
Tor Atle Rosness Knut Engedal Zeina Chemali

Early onset Alzheimer’s disease (EOAD) poses considerable challenges to physicians both in diagnostics and treatment, to patients and caregivers trying to cope with a debilitating illness at a young age and a healthcare system that is not geared to cater to degenerating illnesses striking young persons (Van Vliet et al., 2012). Routine procedures and screening measures for elderly people possib...

Journal: :Alzheimers & Dementia 2023

Background Early Onset Alzheimer Disease (EOAD, age at onset [AAO] < = 65) is a severe form of AD, often occurring when patients are still caring for children or adults. Despite this, most genetic studies EOAD have focused on autosomal dominant forms, and there little understanding similarities differences between early late forms AD (LOAD, [AAO]>65). To address we present genome-wide associati...

2016
Eva Bagyinszky Sun Ah Park Hyung Jun Kim Seong Hye Choi Seong Soo A An Sang Yun Kim

In this study, we report a first 226leucine (Leu) mutation to phenylalanine (Phe) in (PSEN1, CTC>TTC, L226F) in Asia from a Korean early-onset Alzheimer's disease (EOAD) patient. Polymerase chain reaction (PCR)-single strand conformation polymorphism, sequencing, and in silico predictions were performed. Previously, L226F was reported in EOAD patients by Zekanowski et al and Gómez-Tortosa et al...

Journal: :Dementia and geriatric cognitive disorders 2012
Byoung Seok Ye Sang Won Seo Yunhwan Lee Seong Yoon Kim Seong Hye Choi Young Min Lee Do Hoon Kim Hyun Jeong Han Duk L Na Eun-Joo Kim

BACKGROUND Amnestic mild cognitive impairment (aMCI) is regarded as a prodromal stage of Alzheimer's disease (AD). Given that patients with early-onset AD (EOAD) and with late-onset AD (LOAD) are known to have different clinical courses, symptoms and neuroimaging findings, early-onset (EOMCI) and late-onset aMCI (LOMCI) might be expected to have similar differences as EOAD versus LOAD. METHOD...

Journal: :Psychiatria Danubina 2010
Harveer Dev Mark Agius Rashid Zaman

INTRODUCTION We discuss the case of a 51 year old former mid-wife presented to the NHS Luton and Bedfordshire psychiatric services with a 2 year history of increasing forgetfulness with significant impairment to her daily function. She was diagnosed with non-familial early-onset Alzheimer's Disease (EOAD) and started on 8mg daily of the acetylcholinesterase inhibitor Galantamine. METHODS The ...

Journal: :JAMA neurology 2015
Joseph H Lee Rong Cheng Badri Vardarajan Rafael Lantigua Dolly Reyes-Dumeyer Ward Ortmann Robert R Graham Tushar Bhangale Timothy W Behrens Martin Medrano Ivonne Z Jiménez-Velázquez Richard Mayeux

IMPORTANCE The present study identified potential genetic modifiers that may delay or accelerate age at onset of familial Alzheimer disease (AD) by examining age at onset in PSEN1 mutation carrier families, and further investigation of these modifiers may provide insight into the pathobiology of AD and potential therapeutic measures. OBJECTIVE To identify genetic variants that modify age at o...

2017
Hélène-Marie Lanoiselée Gaël Nicolas David Wallon Anne Rovelet-Lecrux Morgane Lacour Stéphane Rousseau Anne-Claire Richard Florence Pasquier Adeline Rollin-Sillaire Olivier Martinaud Muriel Quillard-Muraine Vincent de la Sayette Claire Boutoleau-Bretonniere Frédérique Etcharry-Bouyx Valérie Chauviré Marie Sarazin Isabelle le Ber Stéphane Epelbaum Thérèse Jonveaux Olivier Rouaud Mathieu Ceccaldi Olivier Félician Olivier Godefroy Maite Formaglio Bernard Croisile Sophie Auriacombe Ludivine Chamard Jean-Louis Vincent Mathilde Sauvée Cecilia Marelli-Tosi Audrey Gabelle Canan Ozsancak Jérémie Pariente Claire Paquet Didier Hannequin Dominique Campion

BACKGROUND Amyloid protein precursor (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2) mutations cause autosomal dominant forms of early-onset Alzheimer disease (AD-EOAD). Although these genes were identified in the 1990s, variant classification remains a challenge, highlighting the need to colligate mutations from large series. METHODS AND FINDINGS We report here a novel update (2012-201...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید